Journal of Inherited Metabolic Disease · 2000 · 45 citations · 24 references
MedicineNeurosciencePharmacologyCellular NeurobiologyNeurochemistryNeuropharmacologyCentral Nervous System ToxicityNeuroprotectionNeurotoxic AgentsNeurotoxic MechanismsNeurotoxicity MechanismsNeurologic Toxicity ReversalNeuroprotective AgentsNeurotoxic ActionNeurotoxicity Pathology
We have recently demonstrated that incubation of cultured rat hippocampal neurons with conduritol beta-epoxide (CBE), an inhibitor of glucocerebrosidase, the enzyme defective in Gaucher disease, results in changes in intracellular morphology and in functional calcium stores. Changes in levels of functional calcium stores are directly related to neuronal cell death. We now show that neurons incubated with either CBE or a non-hydrolysable analogue of GlcCer (glucosylthioceramide), are more sensitive to the toxic effects of high concentrations of glutamate and of a variety of metabolic inhibitors. A linear relationship exists between level of accumulation of GlcCer and the extent of neuronal cell death. The deleterious effects of elevated GlcCer levels can be completely reversed by addition of human glucocerebrosidase (imiglucerase) to the culture medium. Imiglucerase is internalized to lysosomes, where it presumably degrades excess GlcCer. This suggests that the limited success of enzyme replacement therapy in neuronopathic forms of Gaucher disease is not due to lack of efficacy of glucocerebroside in degrading GlcCer in neurons of the central nervous system, and adds impetus to attempts to develop ways to efficiently deliver glucocerebrosidase to the brains of neurologically compromised Gaucher disease patients.
24
Eduard Korkotian, Andreas Schwarz, Dori Pelled et al. · Journal of Biological Chemistry · 1999 · 182 citations · Full text
A Regulatory Role for Sphingolipids in Neuronal Growth
Andreas Schwarz, Elizabeth Rapaport, Koret Hirschberg et al. · Journal of Biological Chemistry · 1995 · 158 citations · Full text